InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Huang Jane, Chief Medical Officer, Hematology. Insider active across 2 companies, notably BeiGene, Ltd.. Cumulatively, 24 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €1.6m. Activity tracked since 29 April 2021. The latest transaction was disclosed on 14 December 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Huang Jane
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报24 总计
9,375 股Common StockSEC:0001683913-25-000004:0
9,375 股Common StockSEC:0001562180-25-005346:0
9,375 股Common StockSEC:0001562180-25-003036:0
9,375 股Common StockSEC:0001562180-25-000237:0
9,375 股Common StockSEC:0001562180-24-007253:0
9,375 股Common StockSEC:0001562180-24-005641:0
9,375 股Common StockSEC:0001562180-24-003347:0
9,375 股Common StockSEC:0001562180-24-000338:0
9,375 股Common StockSEC:0001562180-23-007230:0
9,375 股Common StockSEC:0001209191-23-041553:0
37,500 股Common StockSEC:0001562180-23-003481:0
1,500 股@ US$119.960.0005% mcap2.2% 占其流量American Depositary SharesSEC:0001651308-21-000255:0
14,820 股0Ordinary SharesSEC:0001651308-21-000237:0
1,500 股@ US$119.964.4% 占其流量American Depositary SharesSEC:0001651308-21-000230:0
1,500 股@ US$119.964.3% 占其流量American Depositary SharesSEC:0001651308-21-000209:0
6,000 股@ US$119.9616.9% 占其流量American Depositary SharesSEC:0001651308-21-000196:0
4,219 股@ US$355.370634.9% 占其流量American Depositary SharesSEC:0001651308-21-000192:0
7,163 股0Ordinary SharesSEC:0001651308-21-000188:0
6,914 股@ US$160.4025.8% 占其流量American Depositary SharesSEC:0001651308-21-000154:0
425 股@ US$365.003.6% 占其流量American Depositary SharesSEC:0001651308-21-000140:0
25,350 股0Ordinary SharesSEC:0001651308-21-000126:0
603 股@ US$351.55154.8% 占其流量American Depositary SharesSEC:0001651308-21-000107:0
7,189 股0Ordinary SharesSEC:0001651308-21-000099:0
1,500 股@ US$29.491.0% 占其流量American Depositary SharesSEC:0001651308-21-000078:0
24 条申报中的 24 条
About Huang Jane
Huang Jane is Chief Medical Officer, Hematology. She has filed 24 filings in total, and the sampled recent filings cover the period from 2021-05-03 to 2025-10-07, with sell transactions totaling EUR 1573205 and no buys, mainly related to BeiGene, Ltd. and Prelude Therapeutics Inc.
